PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference
Details on the presentation can be found below.
Goldman Sachs Annual Global Healthcare Conference
A replay of the presentation will be available by visiting the “Events & Presentations” section of the
About PMV Pharma
PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr.
For Investors & Media:
Chief Financial Officer
Source: PMV Pharmaceuticals, Inc.